Amedisys Home Health and Hospice Care (AMED) Expected to Post Quarterly Sales of $396.66 Million

Brokerages expect that Amedisys Home Health and Hospice Care (NASDAQ:AMED) will report sales of $396.66 million for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Amedisys Home Health and Hospice Care’s earnings, with the lowest sales estimate coming in at $392.50 million and the highest estimate coming in at $403.67 million. Amedisys Home Health and Hospice Care posted sales of $370.46 million during the same quarter last year, which would indicate a positive year over year growth rate of 7.1%. The company is expected to issue its next quarterly earnings results on Tuesday, May 1st.

On average, analysts expect that Amedisys Home Health and Hospice Care will report full-year sales of $396.66 million for the current fiscal year, with estimates ranging from $1.61 billion to $1.64 billion. For the next year, analysts forecast that the firm will post sales of $1.73 billion per share, with estimates ranging from $1.68 billion to $1.76 billion. Zacks’ sales calculations are an average based on a survey of analysts that follow Amedisys Home Health and Hospice Care.

How to Become a New Pot Stock Millionaire

Amedisys Home Health and Hospice Care (NASDAQ:AMED) last released its earnings results on Tuesday, February 27th. The health services provider reported $0.56 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.02). Amedisys Home Health and Hospice Care had a net margin of 1.98% and a return on equity of 15.14%. The business had revenue of $404.24 million for the quarter, compared to the consensus estimate of $394.96 million. During the same quarter in the previous year, the firm earned $0.44 EPS.

Several research firms have weighed in on AMED. BidaskClub upgraded shares of Amedisys Home Health and Hospice Care from a “buy” rating to a “strong-buy” rating in a research note on Friday. Zacks Investment Research lowered shares of Amedisys Home Health and Hospice Care from a “buy” rating to a “hold” rating in a research report on Tuesday, March 20th. Royal Bank of Canada upgraded shares of Amedisys Home Health and Hospice Care from a “sector perform” rating to an “outperform” rating in a research report on Monday, March 19th. TheStreet lowered shares of Amedisys Home Health and Hospice Care from a “b” rating to a “c+” rating in a research report on Wednesday, February 28th. Finally, Robert W. Baird set a $66.00 price target on shares of Amedisys Home Health and Hospice Care and gave the stock a “hold” rating in a research report on Thursday, March 1st. Five investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. Amedisys Home Health and Hospice Care presently has an average rating of “Buy” and a consensus price target of $63.18.

AMED stock traded down $1.08 during trading on Tuesday, hitting $64.45. 147,802 shares of the company’s stock traded hands, compared to its average volume of 224,205. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.45 and a quick ratio of 1.45. Amedisys Home Health and Hospice Care has a 52 week low of $45.60 and a 52 week high of $65.91. The firm has a market cap of $2,190.33, a price-to-earnings ratio of 29.16, a PEG ratio of 1.23 and a beta of 0.65.

Hedge funds have recently bought and sold shares of the stock. Wells Fargo & Company MN lifted its holdings in Amedisys Home Health and Hospice Care by 29.7% in the third quarter. Wells Fargo & Company MN now owns 1,484,041 shares of the health services provider’s stock worth $83,048,000 after purchasing an additional 339,825 shares during the period. Copper Rock Capital Partners LLC lifted its holdings in Amedisys Home Health and Hospice Care by 3.6% in the fourth quarter. Copper Rock Capital Partners LLC now owns 596,014 shares of the health services provider’s stock worth $31,386,000 after purchasing an additional 20,699 shares during the period. Sterling Capital Management LLC lifted its holdings in Amedisys Home Health and Hospice Care by 15.8% in the third quarter. Sterling Capital Management LLC now owns 16,654 shares of the health services provider’s stock worth $932,000 after purchasing an additional 2,268 shares during the period. Bank of New York Mellon Corp lifted its holdings in Amedisys Home Health and Hospice Care by 10.8% in the third quarter. Bank of New York Mellon Corp now owns 846,575 shares of the health services provider’s stock worth $47,375,000 after purchasing an additional 82,247 shares during the period. Finally, Strs Ohio acquired a new stake in Amedisys Home Health and Hospice Care in the fourth quarter worth about $1,027,000. 96.71% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.tickerreport.com/banking-finance/3341633/amedisys-home-health-and-hospice-care-amed-expected-to-post-quarterly-sales-of-396-66-million.html.

Amedisys Home Health and Hospice Care Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

Get a free copy of the Zacks research report on Amedisys Home Health and Hospice Care (AMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Amedisys Home Health and Hospice Care (NASDAQ:AMED)

Receive News & Ratings for Amedisys Home Health and Hospice Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Home Health and Hospice Care and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

New Residential Inv  Earning Somewhat Favorable News Coverage, Study Finds
New Residential Inv Earning Somewhat Favorable News Coverage, Study Finds
EPAM Systems  Given Media Impact Rating of 0.16
EPAM Systems Given Media Impact Rating of 0.16
American Homes 4 Rent  Receives Daily News Sentiment Score of 0.20
American Homes 4 Rent Receives Daily News Sentiment Score of 0.20
Datawallet  Reaches 24 Hour Trading Volume of $216,725.00
Datawallet Reaches 24 Hour Trading Volume of $216,725.00
SportyCo 24 Hour Volume Hits $1.27 Million
SportyCo 24 Hour Volume Hits $1.27 Million
Taylor Devices  Rating Lowered to Hold at ValuEngine
Taylor Devices Rating Lowered to Hold at ValuEngine


Leave a Reply

© 2006-2018 Ticker Report. Google+.